Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IDIOPATHIC PARKINSONS-DISEASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rajput, AH
      Levodopa prolongs life expectancy and is non-toxic to substantia nigra

      PARKINSONISM & RELATED DISORDERS
    2. Wenning, GK; Braune, S
      Multiple system atrophy - Pathophysiology and management

      CNS DRUGS
    3. Boesch, SM; Schocke, M; Burk, K; Hollosi, P; Fornai, F; Aichner, FT; Poewe, W; Felber, S
      Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6

      JOURNAL OF MAGNETIC RESONANCE IMAGING
    4. Bennett, JP; Carvey, PM; Hinds, TR; Johnson, RD; Le, WD; Phillips, W; Sethy, VH; Vincenzi, FF; Youdim, MBH
      Mechanisms of action of pramipexole: Putative neuroprotective effects

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    5. Kish, SJ; Kalasinsky, KS; Derkach, P; Schmunk, GA; Guttman, M; Ang, L; Adams, V; Furukawa, Y; Haycock, JW
      Striatal dopaminergic and serotonergic markers in human heroin users

      NEUROPSYCHOPHARMACOLOGY
    6. Hsu, YY; Du, AT; Schuff, N; Weiner, MW
      Magnetic resonance imaging and magnetic resonance spectroscopy in dementias

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    7. Glosser, G
      Neurobehavioral aspects of movement disorders

      NEUROLOGIC CLINICS
    8. Joyce, JN
      Dopamine D-3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

      PHARMACOLOGY & THERAPEUTICS
    9. Doty, RL
      Olfaction

      ANNUAL REVIEW OF PSYCHOLOGY
    10. Van Heertum, RL; Drocea, C; Ichise, M; Lobotesis, K; Fawwaz, RA
      Single photon emission CT and positron emission tomography in the evaluation of neurologic disease

      RADIOLOGIC CLINICS OF NORTH AMERICA
    11. Baker, KB; Montgomery, EB
      Performance on the PD test battery by relatives of patients with progressive supranuclear palsy

      NEUROLOGY
    12. Doty, RL; Mishra, A
      Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis

      LARYNGOSCOPE
    13. Piccini, P; de Yebenez, J; Lees, AJ; Ceravolo, R; Turjanski, N; Pramstaller, P; Brooks, DJ
      Familial progressive supranuclear palsy - Detection of subclinical cases using F-18-dopa and (18)fluorodeoxyglucose positron emission tomography

      ARCHIVES OF NEUROLOGY
    14. Wenning, GK; Tison, F; Scherfler, C; Puschban, Z; Waldner, R; Granata, R; Ghorayeb, I; Poewe, W
      Towards neurotransplantation in multiple system atrophy: Clinical rationale, pathophysiological basis, and preliminary experimental evidence

      CELL TRANSPLANTATION
    15. Pirker, W; Asenbaum, S; Bencsits, G; Prayer, D; Gerschlager, W; Deecke, L; Brucke, T
      [I-123]beta-CIT SPECT in multiple system atrophy, progressive supranuclearpalsy, and corticobasal degeneration

      MOVEMENT DISORDERS
    16. Probst-Cousin, S; Kayser, C; Heuss, D; Neundorfer, B
      30 years of MSA-concept: Review and survey of multiple system atrophy

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    17. Cordato, NJ; Halliday, GM; Harding, AJ; Hely, MA; Morris, JGL
      Regional brain atrophy in progressive supranuclear palsy and Lewy body disease

      ANNALS OF NEUROLOGY
    18. Reinhardt, MJ; Jungling, FD; Krause, TM; Braune, S
      Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    19. Joel, D; Weiner, I
      The connections of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum

      NEUROSCIENCE
    20. Lorenc-Koci, E; Smialowska, M; Antkiewicz-Michaluk, L; Golembiowska, K; Bajkowska, M; Wolfarth, S
      Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine pn the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats

      NEUROSCIENCE
    21. Tison, F
      Changes in clinical diagnostic criteria for multiple system atrophy.

      REVUE NEUROLOGIQUE
    22. Levy, G; Tang, MX; Cote, LJ; Louis, ED; Alfaro, B; Mejia, H; Stern, Y; Marder, K
      Motor impairment in PD - Relationship to incident dementia and age

      NEUROLOGY
    23. Schulz, JB; Lindenau, J; Seyfried, J; Dichgans, J
      Glutathione, oxidative stress and neurodegeneration

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    24. Jenkins, BG; Kraft, E
      Magnetic resonance spectroscopy in toxic encephalopathy and neurodegeneration

      CURRENT OPINION IN NEUROLOGY
    25. Fernandez, HH; Friedman, JH
      The role of atypical antipsychotics in the treatment of movement disorders

      CNS DRUGS
    26. Gill, CE; Khurana, RK; Hibler, RJ
      Occurrence of depressive symptoms in Shy-Drager syndrome

      CLINICAL AUTONOMIC RESEARCH
    27. Araki, T; Tanji, H; Kato, H; Mizugaki, M; Itoyama, Y
      Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    28. Kimber, J; Watson, L; Mathias, CJ
      Neuroendocrine responses to levodopa in multiple system atrophy (MSA)

      MOVEMENT DISORDERS
    29. Piggott, MA; Marshall, EF; Thomas, N; Lloyd, S; Court, JA; Jaros, E; Costa, D; Perry, RH; Perry, EK
      Dopaminergic activities in the human striatum: Rostrocaudal gradients of uptake sites and of D-1 and D-2 but not of D-3 receptor binding or dopamine

      NEUROSCIENCE
    30. Fiskum, G; Murphy, AN; Beal, MF
      Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    31. Kamel, F; Umbach, DM; Munsat, TL; Shefner, JM; Sandler, DP
      Association of cigarette smoking with amyotrophic lateral sclerosis

      NEUROEPIDEMIOLOGY
    32. Cassarino, DS; Bennett, JP
      An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

      BRAIN RESEARCH REVIEWS
    33. Hudnell, HK
      Effects from environmental Mn exposures: A review of the evidence from non-occupational exposure studies

      NEUROTOXICOLOGY
    34. Vion-Dury, J; Salvan, AM; Cozzone, PJ
      Proton magnetic resonance spectrometry for noninvasive exploration of human brain metabolism: current and future clinical applications.

      REVUE NEUROLOGIQUE
    35. Furukawa, Y; Nygaard, TG; Gutlich, M; Rajput, AH; Pifl, C; DiStefano, L; Chang, LJ; Price, K; Shimadzu, M; Hornykiewicz, O; Haycock, JW; Kish, SJ
      Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia

      NEUROLOGY
    36. Ichise, M; Kim, YJ; Ballinger, JR; Vines, D; Erami, SS; Tanaka, F; Lang, AE
      SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

      NEUROLOGY
    37. Kawamoto, Y; Nakamura, S; Akiguchi, I; Kimura, J
      Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    38. Rakshi, JS; Uema, T; Ito, K; Bailey, DL; Morrish, PK; Ashburner, J; Dagher, A; Jenkins, IH; Friston, KJ; Brooks, DJ
      Frontal, midbrain and striatal dopaminergic function in early and advancedParkinson's disease A 3D [F-18]dopa-PET study

      BRAIN
    39. van Duinen, SG; Lammers, GJ; Maat-Schieman, MLC; Roos, RAC
      Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient

      ACTA NEUROPATHOLOGICA
    40. KAUFMANN H
      MULTIPLE SYSTEM ATROPHY

      Current opinion in neurology
    41. INCE PG; PERRY EK; MORRIS CM
      DEMENTIA WITH LEWY BODIES - A DISTINCT NON-ALZHEIMER DEMENTIA SYNDROME

      Brain pathology
    42. Litvan, I; Hutton, M
      Clinical and genetic aspects of progressive supranuclear palsy

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    43. CUMMING P; GJEDDE A
      COMPARTMENTAL ANALYSIS OF DOPA DECARBOXYLATION IN LIVING BRAIN FROM DYNAMIC POSITRON EMISSION TOMOGRAMS

      Synapse
    44. NAUMANN M; WARMUTHMETZ M; HILLERER C; SOLYMOSI L; REINERS K
      H-1 MAGNETIC-RESONANCE SPECTROSCOPY OF THE LENTIFORM NUCLEUS IN PRIMARY FOCAL HAND DYSTONIA

      Movement disorders
    45. FABRE N; BREFEL C; SABATINI U; CELSIS P; MONTASTRUC JL; CHOLLET F; RASCOL O
      NORMAL FRONTAL PERFUSION IN PATIENTS WITH FROZEN GAIT

      Movement disorders
    46. CHENG FC; NI DR; WU MC; KUO JS; CHIA LG
      GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR PROTECTS AGAINST 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED NEUROTOXICITY IN C57BL 6 MICE/

      Neuroscience letters
    47. CRUZSANCHEZ FF; MORAL A; TOLOSA E; DEBELLEROCHE J; ROSSI ML
      EVALUATION OF NEURONAL LOSS, ASTROCYTOSIS AND ABNORMALITIES OF CYTOSKELETAL COMPONENTS OF LARGE MOTOR-NEURONS IN THE HUMAN ANTERIOR HORN INAGING

      Journal of neural transmission
    48. DRAGO J; PADUNGCHAICHOT P; WONG JYF; LAWRENCE AJ; MCMANUS JF; SUMARSONO SH; NATOLI AL; LAKSO M; WREFORD N; WESTPHAL H; KOLA I; FINKELSTEIN DI
      TARGETED EXPRESSION OF A TOXIN GENE TO D1 DOPAMINE-RECEPTOR NEURONS BY CRE-MEDIATED SITE-SPECIFIC RECOMBINATION

      The Journal of neuroscience
    49. MCCANN UD; WONG DF; YOKOI F; VILLEMAGNE V; DANNALS RF; RICAURTE GA
      REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428

      The Journal of neuroscience
    50. KAYE JA
      DIAGNOSTIC CHALLENGES IN DEMENTIA

      Neurology
    51. TANAKA S; CHEN X; XIA Y; KANG DE; MATOH N; SUNDSMO M; THOMAS RG; KATZMAN R; THAL LJ; TROJANOWSKI JQ; SAITOH T; UEDA K; MASLIAH E
      ASSOCIATION OF CYP2D MICROSATELLITE POLYMORPHISM WITH LEWY BODY VARIANT OF ALZHEIMERS-DISEASE

      Neurology
    52. TAKEDA A; HASHIMOTO M; MALLORY M; SUNDSUMO M; HANSEN L; SISK A; MASLIAH E
      ABNORMAL DISTRIBUTION OF THE NON-A-BETA COMPONENT OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR ALPHA-SYNUCLEIN IN LEWY BODY DISEASE AS REVEALED BY PROTEINASE-K AND FORMIC-ACID PRETREATMENT/

      Laboratory investigation
    53. RABINOVIC AD; HASTINGS TG
      ROLE OF ENDOGENOUS GLUTATHIONE IN THE OXIDATION OF DOPAMINE

      Journal of neurochemistry
    54. FLOOR E; WETZEL MG
      INCREASED PROTEIN OXIDATION IN HUMAN SUBSTANTIA-NIGRA PARS COMPACTA IN COMPARISON WITH BASAL GANGLIA AND PREFRONTAL CORTEX MEASURED WITH ANIMPROVED DINITROPHENYLHYDRAZINE ASSAY

      Journal of neurochemistry
    55. HAWKES CH; SHEPHARD BC; GEDDES JF; BODY GD; MARTIN JE
      OLFACTORY DISORDER IN MOTOR-NEURON DISEASE

      Experimental neurology
    56. VERNY M; DUYCKAERTS C
      DEMENTIA WITH LEWY BODIES

      Annales de medecine interne
    57. CLARKE CE; GULLAKSEN E; MACDONALD S; LOWE F
      REFERRAL CRITERIA FOR SPEECH AND LANGUAGE THERAPY ASSESSMENT OF DYSPHAGIA CAUSED BY IDIOPATHIC PARKINSONS-DISEASE

      Acta neurologica Scandinavica
    58. DOTY RL; LI C; BAGLA R; HUANG W; PFEIFFER C; BROSVIC GM; RISSER JM
      SKF-38393 ENHANCES ODOR DETECTION PERFORMANCE

      Psychopharmacology
    59. HU T; DRYHURST G
      ELECTROCHEMICAL AND PEROXIDASE O-2-MEDIATED OXIDATION OF INDOLE-3-ACETIC-ACID AT PHYSIOLOGICAL PH

      Journal of electroanalytical chemistry [1992]
    60. MORRISH PK; RAKSHI JS; BROOKS DJ
      CAN THE NEUROPROTECTIVE EFFICACY OF AN AGENT EVER BE CONCLUSIVELY PROVEN

      European journal of neurology
    61. PERRY E; KAY DWK
      SOME DEVELOPMENTS IN BRAIN AGING AND DEMENTIA

      British journal of biomedical science
    62. SHEN XM; ZHANG F; DRYHURST G
      OXIDATION OF DOPAMINE IN THE PRESENCE OF CYSTEINE - CHARACTERIZATION OF NEW TOXIC PRODUCTS

      Chemical research in toxicology
    63. WATANABE M; KODAMA Y; SHIMIZU K; ICHINOWATARI N
      THE COINCIDENCE OF SCHIZOPHRENIA AND IDIOPATHIC PARKINSONS-DISEASE - SUCCESSFUL TREATMENT WITH A COMBINATION OF ANTIPARKINSONIAN DRUGS AND ATYPICAL ANTIPSYCHOTIC-DRUGS

      Human psychopharmacology
    64. CHAUDHURI KR; ELLIS C; LOVEJONES S; THOMAIDES T; CLIFT S; MATHIAS CJ; PARKES JD
      POSTPRANDIAL HYPOTENSION AND PARKINSONIAN STATE IN PARKINSONS-DISEASE

      Movement disorders
    65. LOUIS ED
      THE SHAKING PALSY, THE FIRST 45 YEARS - A JOURNEY THROUGH THE BRITISHLITERATURE

      Movement disorders
    66. DAVIE CA; BARKER GJ; MACHADO C; MILLER DH; LEES AJ
      PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN STEELE-RICHARDSON-OLSZEWSKI-SYNDROME

      Movement disorders
    67. KLEIN C; BROWN R; WENNING G; QUINN N
      THE COLD HANDS SIGN IN MULTIPLE SYSTEM ATROPHY

      Movement disorders
    68. BRUNE M; BRAUNIG P
      AKATHISIA

      Fortschritte der Neurologie, Psychiatrie
    69. DOTY RL
      STUDIES OF HUMAN OLFACTION FROM THE UNIVERSITY-OF-PENNSYLVANIA SMELL AND TASTE CENTER

      Chemical senses
    70. CAMPBELL JM; PAYNE AP; GILMORE DP; RUSSELL D; MCGADEY J; CLARKE DJ; BRANTON R; DAVIES RW; SUTCLIFFE RG
      AGE-CHANGES IN DOPAMINE LEVELS IN THE CORPUS STRIATUM OF ALBINO SWISS(AS) AND AS AGU MUTANT RATS/

      Neuroscience letters
    71. IRWIN I; DELANNEY L; CHAN P; SANDY MS; DIMONTE DA; LANGSTON JW
      NIGROSTRIATAL MONOAMINE-OXIDASE-A AND MONOAMINIE-OXIDASE-B IN AGING SQUIRREL-MONKEYS AND C57BL 6 MICE/

      Neurobiology of aging
    72. HAO R; MACDONALD RG; EBADI M; SCHMIT JC; PFEIFFER RF
      STABLE INTERACTION BETWEEN G-ACTIN AND NEUROFILAMENT LIGHT SUBUNIT INDOPAMINERGIC-NEURONS

      Neurochemistry international
    73. BAINS JS; SHAW CA
      NEURODEGENERATIVE DISORDERS IN HUMANS - THE ROLE OF GLUTATHIONE IN OXIDATIVE STRESS-MEDIATED NEURONAL DEATH

      Brain research reviews
    74. SHEN XM; DRYHURST G
      FURTHER INSIGHTS INTO THE OXIDATION CHEMISTRY OF NOREPINEPHRINE AND EPINEPHRINE IN THE PRESENCE OF CYSTEINE

      Bioorganic chemistry
    75. WENNING GK; PRAMSTALLER PP; RANSMAYR G; POEWE W
      ATYPICAL PARKINSONIAN SYNDROMES

      Nervenarzt
    76. MARTZKE JS; KOPALA LC; GOOD KP
      OLFACTORY DYSFUNCTION IN NEUROPSYCHIATRIC DISORDERS - REVIEW AND METHODOLOGICAL CONSIDERATIONS

      Biological psychiatry
    77. LITVAN I; GOETZ CG; JANKOVIC J; WENNING GK; BOOTH V; BARTKO JJ; MCKEE A; JELLINGER K; LAI EC; BRANDEL JP; VERNY M; CHAUDHURI KR; PEARCE RKB; AGID Y
      WHAT IS THE ACCURACY OF THE CLINICAL-DIAGNOSIS OF MULTIPLE SYSTEM ATROPHY - A CLINICOPATHOLOGICAL STUDY

      Archives of neurology
    78. ANSARI AA; SUNDSTROM JB
      TRANSPLANTATION OF FETAL TISSUES

      Immunology and allergy clinics of North America
    79. MEARA J
      SEROTONIN AND THE EXTRAPYRAMIDAL SYSTEM - A NEUROLOGICAL PERSPECTIVE

      Human psychopharmacology
    80. ZIJLMANS JCM; POELS PJE; DUYSENS J; VANDERSTRAATEN J; THIEN T; VANTHOF MA; THIJSSEN HOM; HORSTINK MWIM
      QUANTITATIVE GAIT ANALYSIS IN PATIENTS WITH VASCULAR PARKINSONISM

      Movement disorders
    81. BORDET R; BENHADJALI J; DESTEE A; HURTEVENT JF; BOURRIEZ JL; GUIEU JD
      SYMPATHETIC SKIN-RESPONSE AND R-R INTERVAL VARIABILITY IN MULTIPLE SYSTEM ATROPHY AND IDIOPATHIC PARKINSONS-DISEASE

      Movement disorders
    82. BORDET R; BROLY F; DESTEE A; LIBERSA C; LAFITTE JJ
      LACK OF RELATION BETWEEN GENETIC-POLYMORPHISM OF CYTOCHROME P-450IID6AND SPORADIC IDIOPATHIC PARKINSONS-DISEASE

      Clinical neuropharmacology
    83. CAMPBELL JM; PAYNE AP; GILMORE DP; BYRNE JE; RUSSELL D; MCGADEY J; CLARKE DJ; DAVIES RW; SUTCLIFFE RG
      NEOSTRIATAL DOPAMINE DEPLETION AND LOCOMOTOR ABNORMALITIES DUE TO THEALBINO SWISS RAT AGU MUTATION

      Neuroscience letters
    84. SHEN XM; DRYHURST G
      INFLUENCE OF L-CYSTEINE ON THE OXIDATION CHEMISTRY OF (-)-EPINEPHRINE- FORMATION OF CYSTEINYL CONJUGATES AND NOVEL DIHYDROBENZOTHIAZINES

      Bioorganic chemistry
    85. GASSER T; MULLERMYHSOK B; SUPALA A; ZIMMER E; WIEDITZ G; WSZOLEK ZK; VIEREGGE P; BONIFATI V; OERTEL WH
      THE CYP2D6B ALLELE IS NOT OVERREPRESENTED IN A POPULATION OF GERMAN PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE

      Journal of Neurology, Neurosurgery and Psychiatry
    86. MCKEOWN DA; DOTY RL; PERL DP; FRYE RE; SIMMS I; MESTER A
      OLFACTORY FUNCTION IN YOUNG ADOLESCENTS WITH DOWNS-SYNDROME

      Journal of Neurology, Neurosurgery and Psychiatry
    87. SMITH GDP; MATHIAS CJ
      DIFFERENCES IN CARDIOVASCULAR-RESPONSES TO SUPINE EXERCISE AND TO STANDING AFTER EXERCISE IN 2 CLINICAL SUBGROUPS OF SHY-DRAGER SYNDROME (MULTIPLE SYSTEM ATROPHY)

      Journal of Neurology, Neurosurgery and Psychiatry
    88. ZHANG F; DRYHURST G
      INFLUENCE OF GLUTATHIONE ON THE OXIDATION CHEMISTRY OF THE CATECHOLAMINERGIC NEUROTRANSMITTER DOPAMINE

      Journal of electroanalytical chemistry [1992]
    89. WAGSTAFF AJ; BRYSON HM
      CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH SCHIZOPHRENIA WHO ARE UNRESPONSIVE TO OR INTOLERANT OF CLASSICAL ANTIPSYCHOTIC AGENTS

      CNS DRUGS
    90. SALZMAN C; VACCARO B; LIEFF J; WEINER A
      CLOZAPINE IN OLDER PATIENTS WITH PSYCHOSIS AND BEHAVIORAL DISRUPTION

      The American journal of geriatric psychiatry
    91. KISH SJ; ZHONG XH; HORNYKIEWICZ O; HAYCOCK JW
      STRIATAL 3,4-DIHYDROXYPHENYLALANINE DECARBOXYLASE IN AGING - DISPARITY BETWEEN POSTMORTEM AND POSITRON EMISSION TOMOGRAPHY STUDIES

      Annals of neurology
    92. GAGNON C; GOMEZMANCILLA B; MARKSTEIN R; BEDARD PJ; DIPAOLO T
      EFFECT OF ADDING THE D-1 AGONIST CY-208-243 TO CHRONIC BROMOCRIPTINE TREATMENT OF MPTP-MONKEYS - REGIONAL CHANGES OF BRAIN DOPAMINE-RECEPTORS

      Progress in neuro-psychopharmacology & biological psychiatry
    93. GUIMON J; BLANCO J; CASO C
      L-DOPA CARBIDOPA TREATMENT OF SENILE DEMENTIA - A CONTROL STUDY

      The European journal of psychiatry
    94. GERHARDT GA; CASS WA; HENSON M; ZHANG ZM; OVADIA A; HOFFER BJ; GASH DM
      AGE-RELATED-CHANGES IN POTASSIUM-EVOKED OVERFLOW OF DOPAMINE IN THE STRIATUM OF THE RHESUS-MONKEY

      Neurobiology of aging
    95. TISON F; WENNING GK; DANIEL SE; QUINN NP
      MULTIPLE SYSTEM ATROPHY WITH LEWY BODIES

      Revue neurologique
    96. GODEFROY O; VERMERSCH P
      SUBCORTICAL DEMENTIA - IS A REVISION OF T HE CONCEPT NECESSARY

      Revue neurologique
    97. BOWLING AC; BEAL MF
      BIOENERGETIC AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES

      Life sciences
    98. MONTINE TJ; FARRIS DB; GRAHAM DG
      COVALENT CROSS-LINKING OF NEUROFILAMENT PROTEINS BY OXIDIZED CATECHOLS AS A POTENTIAL MECHANISM OF LEWY BODY FORMATION

      Journal of neuropathology and experimental neurology
    99. FUKUI T; SATO Y; ICHIKAWA H; TAKEUCHI T; SUGITA K; TSUKAGOSHI H
      EVALUATION OF INFLUENTIAL FACTORS OF COGNITIVE IMPAIRMENTS IN IDIOPATHIC PARKINSONS-DISEASE

      European neurology
    100. MAGALHAES M; WENNING GK; DANIEL SE; QUINN NP
      AUTONOMIC DYSFUNCTION IN PATHOLOGICALLY CONFIRMED MULTIPLE SYSTEM ATROPHY AND IDIOPATHIC PARKINSONS-DISEASE - A RETROSPECTIVE COMPARISON

      Acta neurologica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 10:55:35